Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ethan B Russo

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Frontiers in Pharmacology|September 30, 2016
Current Therapeutic Cannabis Controversies and Clinical Trial Design IssuesEthan B Russo
Neuro Endocrinology Letters|May 26, 2004
Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?Ethan B Russo
Neuro Endocrinology Letters|April 12, 2008
Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?Ethan B Russo
Annals of Internal Medicine|October 8, 2003
Echinacea for the common coldEthan B Russo
Frontiers in Integrative Neuroscience|November 9, 2018
Cannabis Therapeutics and the Future of NeurologyEthan B Russo
Epilepsy & Behavior : E&B|December 20, 2016
Cannabis and epilepsy: An ancient treatment returns to the foreEthan B Russo
Neurology|February 26, 2003
Safety, tolerability, and efficacy of orally administered cannabinoids in MSEthan B Russo
Therapeutics and Clinical Risk Management|August 30, 2008
Cannabinoids in the management of difficult to treat painEthan B Russo
Advances in Pharmacology (San Diego, Calif.)|August 23, 2017
Cannabis Pharmacology: The Usual Suspects and a Few Promising LeadsEthan B Russo, Jahan Marcu
Cannabis and Cannabinoid Research|September 2, 2017
The <i>Cannabis sativa</i> Versus <i>Cannabis indica</i> Debate: An Interview with Ethan Russo, MDDaniele Piomelli, Ethan B Russo
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Frontiers in Pharmacology|September 30, 2016
Current Therapeutic Cannabis Controversies and Clinical Trial Design IssuesEthan B Russo
Neuro Endocrinology Letters|May 26, 2004
Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?Ethan B Russo
Neuro Endocrinology Letters|April 12, 2008
Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?Ethan B Russo
Annals of Internal Medicine|October 8, 2003
Echinacea for the common coldEthan B Russo
Frontiers in Integrative Neuroscience|November 9, 2018
Cannabis Therapeutics and the Future of NeurologyEthan B Russo
Epilepsy & Behavior : E&B|December 20, 2016
Cannabis and epilepsy: An ancient treatment returns to the foreEthan B Russo
Neurology|February 26, 2003
Safety, tolerability, and efficacy of orally administered cannabinoids in MSEthan B Russo
Therapeutics and Clinical Risk Management|August 30, 2008
Cannabinoids in the management of difficult to treat painEthan B Russo
Advances in Pharmacology (San Diego, Calif.)|August 23, 2017
Cannabis Pharmacology: The Usual Suspects and a Few Promising LeadsEthan B Russo, Jahan Marcu
Cannabis and Cannabinoid Research|September 2, 2017
The <i>Cannabis sativa</i> Versus <i>Cannabis indica</i> Debate: An Interview with Ethan Russo, MDDaniele Piomelli, Ethan B Russo
Pageof 4